Paper36908748
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.
Aggarwal A and 17 others. JHEP Rep, 2023. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells. Papers, record 36908748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36908748
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27453547 | HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant. | Gastroenterology | 2016 | https://conductscience.org/library/papers/27453547 | PubMed |
| 2 | 10559280 | Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor. | J Virol | 1999 | https://conductscience.org/library/papers/10559280 | PubMed |
| 3 | 35363817 | Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy. | PLoS One | 2022 | https://conductscience.org/library/papers/35363817 | PubMed |
| 4 | 19052126 | Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. | N Engl J Med | 2008 | https://conductscience.org/library/papers/19052126 | PubMed |
| 5 | 27027237 | Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27027237 | PubMed |
| 6 | 33652619 | HBV-Integration Studies in the Clinic: Role in the Natural History of Infection. | Viruses | 2021 | https://conductscience.org/library/papers/33652619 | PubMed |
| 7 | 33563643 | Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. | Gut | 2022 | https://conductscience.org/library/papers/33563643 | PubMed |
| 8 | 20512987 | Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. | Hepatology | 2010 | https://conductscience.org/library/papers/20512987 | PubMed |
| 9 | 15188170 | Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. | Gastroenterology | 2004 | https://conductscience.org/library/papers/15188170 | PubMed |
| 10 | 25132147 | Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors. | Hepatology | 2015 | https://conductscience.org/library/papers/25132147 | PubMed |
| 11 | 22634754 | Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. | Nat Genet | 2012 | https://conductscience.org/library/papers/22634754 | PubMed |
| 12 | 34950863 | Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection. | JHEP Rep | 2022 | https://conductscience.org/library/papers/34950863 | PubMed |
| 13 | 1714871 | Export of intracellular HBsAg in chronic hepatitis B virus infection is related to viral replication. | Hepatology | 1991 | https://conductscience.org/library/papers/1714871 | PubMed |
| 14 | 28427875 | EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. | J Hepatol | 2017 | https://conductscience.org/library/papers/28427875 | PubMed |
| 15 | 23364953 | Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load. | Hepatology | 2013 | https://conductscience.org/library/papers/23364953 | PubMed |
| 16 | 26901811 | In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection. | J Clin Invest | 2016 | https://conductscience.org/library/papers/26901811 | PubMed |
| 17 | 18713304 | Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study. | J Gastroenterol Hepatol | 2008 | https://conductscience.org/library/papers/18713304 | PubMed |
| 18 | 28394272 | HBV DNA Integration: Molecular Mechanisms and Clinical Implications. | Viruses | 2017 | https://conductscience.org/library/papers/28394272 | PubMed |
| 19 | 34995536 | Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation. | Gastroenterology | 2022 | https://conductscience.org/library/papers/34995536 | PubMed |
| 20 | 3886705 | Widespread presence of cytoplasmic HBcAg in hepatitis B infected liver detected by improved immunochemical methods. | J Clin Pathol | 1985 | https://conductscience.org/library/papers/3886705 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936208 | Metabolic-epigenetic regulation of the HBV cccDNA reservoir: pathways underpinning viral persistence. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42936208 | PubMed |
| 42503913 | [Clinical significance and occurrence mechanism of hepatitis B virus DNA integration]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42503913 | PubMed |
| 42172500 | Secretion of the HBV small surface antigen is driven by an ER autophagic pathway. | Hepatol Commun | 2026 | https://conductscience.org/library/papers/42172500 | PubMed |
| 42092282 | Spatial-quantitative profiling of intrahepatic HBsAg heterogeneity and clustered distribution in chronic HBV infection. | JHEP Rep | 2026 | https://conductscience.org/library/papers/42092282 | PubMed |
| 41810427 | Spatial transcriptional profiling of CHB liver biopsies reveals an undetected population of zonally biased HBV-integrated cells. | JHEP Rep | 2026 | https://conductscience.org/library/papers/41810427 | PubMed |
| 41754527 | Direct Viral Mechanisms Underlying the Onset of HBV-Related Hepatocellular Carcinoma and Implications for Therapeutic Strategies. | Viruses | 2026 | https://conductscience.org/library/papers/41754527 | PubMed |
| 41196060 | Replication-driven HBV cccDNA loss in chimeric mice with humanized livers. | J Virol | 2025 | https://conductscience.org/library/papers/41196060 | PubMed |
| 40871291 | Virological Insights from ARC-520 siRNA and Entecavir Treated Chronically HBV-Infected Patients and Chimpanzees. | Microorganisms | 2025 | https://conductscience.org/library/papers/40871291 | PubMed |
| 40803751 | Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. | Gut | 2025 | https://conductscience.org/library/papers/40803751 | PubMed |
| 40764061 | Spatial single-cell omics: new insights into liver diseases. | Gut | 2026 | https://conductscience.org/library/papers/40764061 | PubMed |
| 40714040 | Scientific and medical evidence informing expansion of hepatitis B treatment guidelines. | Lancet Gastroenterol Hepatol | 2025 | https://conductscience.org/library/papers/40714040 | PubMed |
| 40035711 | Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B. | Emerg Microbes Infect | 2025 | https://conductscience.org/library/papers/40035711 | PubMed |
| 39944365 | New dimension in viral hepatitis research. | eGastroenterology | 2024 | https://conductscience.org/library/papers/39944365 | PubMed |
| 39920779 | Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study. | Virol J | 2025 | https://conductscience.org/library/papers/39920779 | PubMed |
| 39772138 | New Insights on Hepatitis B Virus Viral Transcription in Single Hepatocytes. | Viruses | 2024 | https://conductscience.org/library/papers/39772138 | PubMed |
| 39284813 | Leveraging immuno-fluorescence data to reduce pathologist annotation requirements in lung tumor segmentation using deep learning. | Sci Rep | 2024 | https://conductscience.org/library/papers/39284813 | PubMed |
| 39253701 | Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretion. | JHEP Rep | 2024 | https://conductscience.org/library/papers/39253701 | PubMed |
| 39149129 | Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics. | eGastroenterology | 2024 | https://conductscience.org/library/papers/39149129 | PubMed |
| 39109538 | TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/39109538 | PubMed |
| 38934109 | Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting". | Clin Mol Hepatol | 2024 | https://conductscience.org/library/papers/38934109 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36908748
GET https://conductscience.org/api/papers/v1/36908748/references?page=2